Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

A EUFOREA comment on a lost comorbidity of asthma

Conti, Diego M. ; Hellings, Peter W. ; Diamant, Zuzana LU ; Bjermer, Leif LU ; Jesenak, Milos ; Backer, Vibeke ; Fokkens, Wytske ; Lau, Susanne ; Van Staeyen, Elizabeth and Scadding, Glenis K. (2023) In Allergy, Asthma and Clinical Immunology 19(1).
Abstract

“Epidemiology of comorbidities and their association with asthma control” (Tomisa, G., Horváth, A., Sánta, B. et al. Epidemiology of comorbidities and their association with asthma control. Allergy Asthma Clin Immunol 17, 95 (2021). https://doi.org/10.1186/s13223-021-00598-3) is an interesting paper reflecting data collection from more than 12,000 asthmatic patients in Hungary regarding their condition and associated comorbidities. We found it valuable that the paper provides an overview of asthma comorbidities not usually considered in similar reports. Nevertheless, we believe that chronic rhinosinusitis (CRS) with or without nasal polyps (CRSwNP or CRSsNP) should have been listed due to its high incidence and prevalence, its... (More)

“Epidemiology of comorbidities and their association with asthma control” (Tomisa, G., Horváth, A., Sánta, B. et al. Epidemiology of comorbidities and their association with asthma control. Allergy Asthma Clin Immunol 17, 95 (2021). https://doi.org/10.1186/s13223-021-00598-3) is an interesting paper reflecting data collection from more than 12,000 asthmatic patients in Hungary regarding their condition and associated comorbidities. We found it valuable that the paper provides an overview of asthma comorbidities not usually considered in similar reports. Nevertheless, we believe that chronic rhinosinusitis (CRS) with or without nasal polyps (CRSwNP or CRSsNP) should have been listed due to its high incidence and prevalence, its association with asthma which is also endorsed in both GINA and EPOS, as well as in several peer-reviewed scientific papers, and to reflect the role of this comorbidity in poor control and a most severe presentation of asthma for the patient. Consequently, several targeted therapies (especially monoclonal antibodies) used for several years in severe forms of asthma are now indicated also for the effective treatment of nasal polyps.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Allergic rhinitis, Asthma, Chronic rhinosinusitis with nasal polyps, Chronic rhinosinusitis without nasal polyps, Comorbidities
in
Allergy, Asthma and Clinical Immunology
volume
19
issue
1
article number
56
publisher
BioMed Central (BMC)
external identifiers
  • scopus:85163859937
  • pmid:37391838
ISSN
1710-1484
DOI
10.1186/s13223-023-00816-0
language
English
LU publication?
yes
id
2bacd317-92cc-4378-b029-de88f54d1a13
date added to LUP
2023-08-29 14:49:43
date last changed
2024-12-15 03:05:44
@article{2bacd317-92cc-4378-b029-de88f54d1a13,
  abstract     = {{<p>“Epidemiology of comorbidities and their association with asthma control” (Tomisa, G., Horváth, A., Sánta, B. et al. Epidemiology of comorbidities and their association with asthma control. Allergy Asthma Clin Immunol 17, 95 (2021). https://doi.org/10.1186/s13223-021-00598-3) is an interesting paper reflecting data collection from more than 12,000 asthmatic patients in Hungary regarding their condition and associated comorbidities. We found it valuable that the paper provides an overview of asthma comorbidities not usually considered in similar reports. Nevertheless, we believe that chronic rhinosinusitis (CRS) with or without nasal polyps (CRSwNP or CRSsNP) should have been listed due to its high incidence and prevalence, its association with asthma which is also endorsed in both GINA and EPOS, as well as in several peer-reviewed scientific papers, and to reflect the role of this comorbidity in poor control and a most severe presentation of asthma for the patient. Consequently, several targeted therapies (especially monoclonal antibodies) used for several years in severe forms of asthma are now indicated also for the effective treatment of nasal polyps.</p>}},
  author       = {{Conti, Diego M. and Hellings, Peter W. and Diamant, Zuzana and Bjermer, Leif and Jesenak, Milos and Backer, Vibeke and Fokkens, Wytske and Lau, Susanne and Van Staeyen, Elizabeth and Scadding, Glenis K.}},
  issn         = {{1710-1484}},
  keywords     = {{Allergic rhinitis; Asthma; Chronic rhinosinusitis with nasal polyps; Chronic rhinosinusitis without nasal polyps; Comorbidities}},
  language     = {{eng}},
  number       = {{1}},
  publisher    = {{BioMed Central (BMC)}},
  series       = {{Allergy, Asthma and Clinical Immunology}},
  title        = {{A EUFOREA comment on a lost comorbidity of asthma}},
  url          = {{http://dx.doi.org/10.1186/s13223-023-00816-0}},
  doi          = {{10.1186/s13223-023-00816-0}},
  volume       = {{19}},
  year         = {{2023}},
}